(+)-catechin multiple interactions EXP 6480464 Catechin inhibits the reaction [Dietary Fats results in increased expression of LPL mRNA] CTD PMID:23365609 (+)-catechin multiple interactions ISO RGD:70836 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of LPL mRNA CTD PMID:24763279 (20S)-ginsenoside Rh1 increases secretion ISO RGD:10876 6480464 ginsenoside Rh1 results in increased secretion of LPL protein CTD PMID:8988629 (R)-noradrenaline increases expression EXP 6480464 Norepinephrine results in increased expression of LPL mRNA CTD PMID:9032464 (R)-noradrenaline multiple interactions EXP 6480464 Prazosin inhibits the reaction [Norepinephrine results in increased expression of LPL mRNA], Propranolol inhibits the reaction [Norepinephrine results in increased expression of LPL mRNA] CTD PMID:9032464 (RS)-coclaurine multiple interactions ISO RGD:10876 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of LPL mRNA CTD PMID:28843594 (RS)-norcoclaurine multiple interactions ISO RGD:10876 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of LPL mRNA CTD PMID:28843594 (S)-coclaurine multiple interactions ISO RGD:10876 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of LPL mRNA CTD PMID:28843594 (S)-nicotine increases expression ISO RGD:10876 6480464 Nicotine results in increased expression of LPL mRNA CTD PMID:21955143 1,1-dichloroethene decreases expression ISO RGD:10876 6480464 vinylidene chloride results in decreased expression of LPL mRNA CTD PMID:26682919 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of LPL mRNA CTD PMID:17522070 , PMID:25380136 15-deoxy-Delta(12,14)-prostaglandin J2 increases expression ISO RGD:10876 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 results in increased expression of LPL mRNA CTD PMID:12021203 17alpha-ethynylestradiol affects expression ISO RGD:10876 6480464 Ethinyl Estradiol affects the expression of LPL mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of LPL mRNA CTD PMID:17557909 17alpha-ethynylestradiol multiple interactions ISO RGD:10876 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LPL mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression ISO RGD:10876 6480464 Ethinyl Estradiol results in decreased expression of LPL mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:10876 6480464 ESR1 protein promotes the reaction [Estradiol results in increased expression of LPL mRNA] more ... CTD PMID:17974624 17beta-estradiol multiple interactions ISO RGD:70836 6480464 [Estradiol binds to ESR2 protein] which results in increased expression of LPL mRNA, [Estradiol co-treated with TGFB1 protein] results in decreased expression of LPL mRNA CTD PMID:20404318 , PMID:30165855 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of LPL mRNA CTD PMID:17522070 17beta-estradiol increases expression ISO RGD:10876 6480464 Estradiol results in increased expression of LPL mRNA CTD PMID:17974624 17beta-estradiol decreases expression ISO RGD:10876 6480464 Estradiol results in decreased expression of LPL mRNA CTD PMID:16643890 17beta-estradiol affects expression ISO RGD:70836 6480464 Estradiol affects the expression of LPL mRNA CTD PMID:14699072 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:10876 6480464 Dihydrotestosterone results in increased expression of LPL mRNA CTD PMID:16990341 2,2',4,4',5,5'-hexachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:20959002 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:10876 6480464 [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:30722647 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:10876 6480464 2 more ... CTD PMID:30294300 2,2',5,5'-tetrachlorobiphenyl increases expression ISO RGD:70836 6480464 2 more ... CTD PMID:21703328 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propanoic acid increases expression EXP 6480464 2 more ... CTD PMID:30920876 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10876 6480464 Tetrachlorodibenzodioxin results in increased expression of LPL mRNA CTD PMID:15800033 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:70836 6480464 Tetrachlorodibenzodioxin results in increased expression of LPL mRNA CTD PMID:28011154 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10876 6480464 Tetrachlorodibenzodioxin affects the expression of LPL mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of LPL mRNA CTD PMID:23238561 , PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases activity ISO RGD:10876 6480464 Tetrachlorodibenzodioxin results in decreased activity of LPL protein CTD PMID:9414485 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of LPL mRNA CTD PMID:20959002 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10876 6480464 Tetrachlorodibenzodioxin results in decreased expression of LPL mRNA CTD PMID:17942748 , PMID:7537747 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10876 6480464 [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:16054899 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:70836 6480464 Tetrachlorodibenzodioxin results in decreased expression of LPL mRNA CTD PMID:20106945 2-amino-2-deoxy-D-glucopyranose 6-phosphate decreases expression ISO RGD:10876 6480464 glucosamine 6-phosphate results in decreased expression of LPL mRNA CTD PMID:19427183 2-butoxyethanol decreases expression ISO RGD:10876 6480464 n-butoxyethanol results in decreased expression of LPL mRNA CTD PMID:19812364 25-hydroxycholesterol decreases expression ISO RGD:70836 6480464 25-hydroxycholesterol results in decreased expression of LPL mRNA CTD PMID:8567968 25-hydroxycholesterol decreases activity ISO RGD:70836 6480464 25-hydroxycholesterol results in decreased activity of LPL protein CTD PMID:8567968 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:20959002 , PMID:32119087 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:70836 6480464 3 more ... CTD PMID:29947894 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:10876 6480464 3 more ... CTD PMID:29216392 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:10876 6480464 tetrabromobisphenol A results in increased expression of LPL mRNA CTD PMID:30496566 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of LPL mRNA CTD PMID:15953391 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid multiple interactions ISO RGD:70836 6480464 MK-886 inhibits the reaction [mangiferin results in increased activity of LPL protein] more ... CTD PMID:15975614 3-aminobenzamide increases expression EXP 6480464 3-aminobenzamide results in increased expression of LPL mRNA CTD PMID:18815186 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:70836 6480464 [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with bis(2-ethylhexyl) 2 more ... CTD PMID:19186324 more ... 3-isobutyl-1-methyl-7H-xanthine increases expression ISO RGD:70836 6480464 1-Methyl-3-isobutylxanthine results in increased expression of LPL mRNA CTD PMID:22645054 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:10876 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [[bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA] more ... CTD PMID:16054899 more ... 3-phenylprop-2-enal decreases expression ISO RGD:10876 6480464 cinnamic aldehyde results in decreased expression of LPL mRNA CTD PMID:21401097 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of LPL mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol increases expression ISO RGD:70836 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of LPL mRNA, bis(4-hydroxyphenyl)sulfone results in increased expression of LPL protein CTD PMID:27003841 , PMID:27685785 4,4'-sulfonyldiphenol increases expression ISO RGD:10876 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of LPL mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol multiple interactions ISO RGD:10876 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [[bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA] more ... CTD PMID:27273607 4-nonylphenol increases expression EXP 6480464 4-nonylphenol results in increased expression of LPL mRNA CTD PMID:24388992 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of LPL mRNA CTD PMID:24780913 7,12-dimethyltetraphene decreases expression EXP 6480464 9 more ... CTD PMID:12376462 7alpha-hydroxycholesterol decreases activity ISO RGD:70836 6480464 cholest-5-en-3 beta, 7 alpha-diol results in decreased activity of LPL protein CTD PMID:8567968 7alpha-hydroxycholesterol decreases expression ISO RGD:70836 6480464 cholest-5-en-3 beta, 7 alpha-diol results in decreased expression of LPL mRNA CTD PMID:8567968 8-Br-cAMP increases expression EXP 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LPL mRNA CTD PMID:9032464 8-Br-cAMP decreases activity ISO RGD:10876 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased activity of LPL protein CTD PMID:9414485 9-cis-retinoic acid multiple interactions ISO RGD:70836 6480464 [Alitretinoin co-treated with 22-hydroxycholesterol] results in increased expression of LPL mRNA, [Alitretinoin co-treated with TO-901317] results in increased expression of LPL mRNA CTD PMID:16142410 9-cis-retinoic acid increases expression ISO RGD:70836 6480464 Alitretinoin results in increased expression of LPL mRNA CTD PMID:16142410 acetamide increases expression EXP 6480464 acetamide results in increased expression of LPL mRNA CTD PMID:31881176 acetylcholine affects response to substance ISO RGD:70836 6480464 LPL protein affects the susceptibility to Acetylcholine CTD PMID:11786490 acrylamide multiple interactions ISO RGD:10876 6480464 Acrylamide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of LPL mRNA], Acrylamide promotes the reaction [Dietary Fats results in increased expression of LPL mRNA] CTD PMID:30409764 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of LPL mRNA CTD PMID:23630614 , PMID:25378103 aldehydo-D-glucosamine 6-phosphate decreases expression ISO RGD:10876 6480464 glucosamine 6-phosphate results in decreased expression of LPL mRNA CTD PMID:19427183 aldehydo-D-glucose decreases activity ISO RGD:10876 6480464 Glucose analog results in decreased activity of LPL protein CTD PMID:9414485 aldehydo-D-glucose multiple interactions ISO RGD:70836 6480464 LPL protein promotes the reaction [Fatty Acids results in increased uptake of Glucose] CTD PMID:20628023 all-trans-retinoic acid decreases expression ISO RGD:10876 6480464 Tretinoin results in decreased expression of LPL mRNA CTD PMID:16368784 all-trans-retinoic acid increases expression ISO RGD:70836 6480464 Tretinoin results in increased expression of LPL mRNA CTD PMID:21934132 all-trans-retinoic acid multiple interactions ISO RGD:10876 6480464 troglitazone inhibits the reaction [Tretinoin results in decreased expression of LPL mRNA] CTD PMID:16368784 Aloe emodin multiple interactions ISO RGD:70836 6480464 aloe emodin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of LPL mRNA] CTD PMID:22645054 alpha-hexachlorocyclohexane increases expression EXP 6480464 alpha-hexachlorocyclohexane results in increased expression of LPL mRNA CTD PMID:17785943 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of LPL mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of LPL mRNA CTD PMID:30779732 anthra[1,9-cd]pyrazol-6(2H)-one increases expression ISO RGD:10876 6480464 pyrazolanthrone results in increased expression of LPL mRNA CTD PMID:21873422 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:10876 6480464 pyrazolanthrone inhibits the reaction [Lipopolysaccharides results in decreased expression of LPL mRNA] CTD PMID:21873422 Aroclor 1254 decreases expression ISO RGD:10876 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of LPL mRNA CTD PMID:23650126 arsenous acid decreases expression ISO RGD:70836 6480464 Arsenic Trioxide results in decreased expression of LPL mRNA CTD PMID:19128835 , PMID:26705709 atorvastatin calcium multiple interactions EXP 6480464 Atorvastatin inhibits the reaction [[Cholesterol co-treated with Cholic Acid] results in increased activity of LPL protein] CTD PMID:30273964 ATP affects response to substance ISO RGD:70836 6480464 LPL protein affects the susceptibility to Adenosine Triphosphate CTD PMID:11786490 benzbromarone increases expression ISO RGD:70836 6480464 Benzbromarone results in increased expression of LPL protein CTD PMID:18274627 benzene increases expression ISO RGD:10876 6480464 Benzene results in increased expression of LPL mRNA CTD PMID:15120971 , PMID:15122651 benzo[a]pyrene decreases expression ISO RGD:70836 6480464 Benzo(a)pyrene results in decreased expression of LPL mRNA CTD PMID:20106945 benzo[a]pyrene increases expression ISO RGD:10876 6480464 Benzo(a)pyrene results in increased expression of LPL mRNA CTD PMID:21569818 beta-carotene decreases expression ISO RGD:10876 6480464 beta Carotene results in decreased expression of LPL mRNA CTD PMID:21569430 beta-D-glucosamine 6-sulfate decreases expression ISO RGD:10876 6480464 glucosamine 6-O-sulfate results in decreased expression of LPL mRNA CTD PMID:19520133 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LPL mRNA CTD PMID:18164116 bezafibrate increases expression ISO RGD:10876 6480464 Bezafibrate results in increased expression of LPL mRNA CTD PMID:12782154 , PMID:19124612 bezafibrate increases activity ISO RGD:70836 6480464 Bezafibrate results in increased activity of LPL protein CTD PMID:11164425 more ... bezafibrate multiple interactions EXP 6480464 [Bezafibrate results in increased activity of LPL protein] which results in decreased abundance of Triglycerides, Bezafibrate inhibits the reaction [Lipopolysaccharides results in decreased expression of LPL mRNA] CTD PMID:17379010 , PMID:9006809 bezafibrate increases activity EXP 6480464 Bezafibrate results in increased activity of LPL protein CTD PMID:2907502 , PMID:9006809 bezafibrate multiple interactions ISO RGD:10876 6480464 PPARA protein affects the reaction [Bezafibrate results in increased expression of LPL mRNA], PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of LPL mRNA] CTD PMID:12782154 , PMID:19124612 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:10876 6480464 [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:22197818 more ... bis(2-ethylhexyl) phthalate increases expression ISO RGD:70836 6480464 Diethylhexyl Phthalate results in increased expression of LPL mRNA CTD PMID:31163220 bis(2-ethylhexyl) phthalate increases expression ISO RGD:10876 6480464 Diethylhexyl Phthalate results in increased expression of LPL mRNA CTD PMID:19245819 bisphenol A multiple interactions ISO RGD:10876 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of LPL mRNA] more ... CTD PMID:15659569 more ... bisphenol A decreases expression ISO RGD:10876 6480464 bisphenol A results in decreased expression of LPL mRNA CTD PMID:27502578 , PMID:30133442 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LPL mRNA CTD PMID:20019905 , PMID:25748669 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of LPL mRNA CTD PMID:24105817 more ... bisphenol A increases expression ISO RGD:70836 6480464 bisphenol A results in increased expression of LPL mRNA, bisphenol A results in increased expression of LPL protein CTD PMID:23090578 more ... bisphenol A increases expression ISO RGD:10876 6480464 bisphenol A results in increased expression of LPL mRNA CTD PMID:15659569 , PMID:30566610 bisphenol A multiple interactions ISO RGD:70836 6480464 [bisphenol A results in decreased expression of LPL mRNA] which affects the abundance of Triglycerides CTD PMID:22662114 bisphenol A decreases expression ISO RGD:70836 6480464 bisphenol A results in decreased expression of LPL mRNA CTD PMID:22662114 Bisphenol A diglycidyl ether increases expression ISO RGD:70836 6480464 2, 2-bis(4-glycidyloxyphenyl)propane results in increased expression of LPL mRNA CTD PMID:22763116 Bisphenol A diglycidyl ether increases expression ISO RGD:10876 6480464 2, 2-bis(4-glycidyloxyphenyl)propane results in increased expression of LPL mRNA CTD PMID:22763116 bisphenol F increases expression ISO RGD:10876 6480464 bisphenol F results in increased expression of LPL mRNA CTD PMID:30951980 Butylbenzyl phthalate multiple interactions ISO RGD:10876 6480464 [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of LPL mRNA, [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of LPL mRNA CTD PMID:26820058 , PMID:30768133 cadmium atom multiple interactions EXP 6480464 [Streptozocin co-treated with Cadmium] results in decreased activity of LPL protein, myricetin inhibits the reaction [[Streptozocin co-treated with Cadmium] results in decreased activity of LPL protein] CTD PMID:25240712 cadmium dichloride multiple interactions ISO RGD:10876 6480464 [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of LPL mRNA CTD PMID:19840844 cadmium dichloride decreases activity EXP 6480464 Cadmium Chloride results in decreased activity of LPL protein CTD PMID:18329778 cadmium sulfate multiple interactions ISO RGD:10876 6480464 cadmium sulfate affects the reaction [MTF1 affects the expression of LPL mRNA] CTD PMID:16221973 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of LPL mRNA CTD PMID:23727198 caffeine multiple interactions ISO RGD:10876 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of LPL mRNA CTD PMID:28843594 caffeine decreases expression ISO RGD:10876 6480464 Caffeine results in decreased expression of LPL mRNA CTD PMID:23727198 calcitriol decreases expression ISO RGD:10876 6480464 Calcitriol results in decreased expression of LPL mRNA CTD PMID:16368784 calcitriol multiple interactions ISO RGD:10876 6480464 troglitazone inhibits the reaction [Calcitriol results in decreased expression of LPL mRNA] CTD PMID:16368784 carbendazim decreases expression ISO RGD:10876 6480464 carbendazim results in decreased expression of LPL protein CTD PMID:30496565 carbon nanotube decreases expression ISO RGD:10876 6480464 Nanotubes, Carbon analog results in decreased expression of LPL mRNA, Nanotubes, Carbon results in decreased expression of LPL mRNA CTD PMID:25620056 carbon nanotube increases expression ISO RGD:10876 6480464 Nanotubes, Carbon analog results in increased expression of LPL mRNA, Nanotubes, Carbon results in increased expression of LPL mRNA CTD PMID:25554681 casticin decreases expression ISO RGD:70836 6480464 casticin results in decreased expression of LPL mRNA CTD PMID:27862857 CGP 12177 increases expression EXP 6480464 CGP 12177 results in increased expression of LPL mRNA CTD PMID:9032464 chenodeoxycholic acid multiple interactions ISO RGD:10876 6480464 Chenodeoxycholic Acid inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of LPL mRNA] CTD PMID:27773935 Chikusetsusaponin-V increases secretion ISO RGD:10876 6480464 ginsenoside Ro results in increased secretion of LPL protein CTD PMID:8988629 chloroform increases expression EXP 6480464 Chloroform results in increased expression of LPL mRNA CTD PMID:17522070 chlorogenic acid multiple interactions EXP 6480464 [tetrahydrocurcumin co-treated with Chlorogenic Acid] results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LPL protein], Chlorogenic Acid results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LPL protein] CTD PMID:20696151 cholesterol increases expression ISO RGD:70836 6480464 Cholesterol results in increased expression of LPL mRNA CTD PMID:26296894 cholesterol multiple interactions EXP 6480464 [Cholesterol co-treated with Cholic Acid] results in increased activity of LPL protein more ... CTD PMID:30273964 cholic acid multiple interactions EXP 6480464 [Cholesterol co-treated with Cholic Acid] results in increased activity of LPL protein more ... CTD PMID:14684380 , PMID:30273964 choline multiple interactions ISO RGD:10876 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of LPL mRNA more ... CTD PMID:20938992 more ... ciguatoxin CTX1B affects expression ISO RGD:10876 6480464 Ciguatoxins affects the expression of LPL mRNA CTD PMID:18353800 ciprofibrate increases expression ISO RGD:10876 6480464 ciprofibrate results in increased expression of LPL mRNA CTD PMID:12771043 ciprofibrate increases activity ISO RGD:70836 6480464 ciprofibrate results in increased activity of LPL protein CTD PMID:8593127 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of LPL mRNA CTD PMID:22023808 cisplatin increases expression ISO RGD:70836 6480464 Cisplatin results in increased expression of LPL mRNA CTD PMID:27594783 clofibrate increases expression ISO RGD:70836 6480464 Clofibrate results in increased expression of LPL protein CTD PMID:226883 clofibrate increases expression ISO RGD:10876 6480464 Clofibrate results in increased expression of LPL mRNA CTD PMID:23811191 clofibrate increases activity ISO RGD:70836 6480464 Clofibrate results in increased activity of LPL protein CTD PMID:417937 , PMID:8593127 clofibrate multiple interactions ISO RGD:10876 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of LPL mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of LPL mRNA] CTD PMID:17585979 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of LPL mRNA CTD PMID:12851107 more ... clozapine decreases expression ISO RGD:10876 6480464 Clozapine results in decreased expression of LPL mRNA, Clozapine results in decreased expression of LPL protein CTD PMID:19682446 clozapine increases expression ISO RGD:10876 6480464 Clozapine results in increased expression of LPL mRNA CTD PMID:17266109 Colforsin dapropate hydrochloride increases expression EXP 6480464 Colforsin results in increased expression of LPL mRNA CTD PMID:9032464 conjugated linoleic acid multiple interactions ISO RGD:10876 6480464 rosiglitazone inhibits the reaction [Linoleic Acids, Conjugated results in decreased expression of LPL mRNA] CTD PMID:17322064 conjugated linoleic acid increases activity ISO RGD:70836 6480464 Linoleic Acids, Conjugated results in increased activity of LPL protein CTD PMID:23073171 conjugated linoleic acid decreases expression ISO RGD:10876 6480464 Linoleic Acids, Conjugated results in decreased expression of LPL mRNA CTD PMID:17322064 copper atom increases expression EXP 6480464 Copper results in increased expression of LPL mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of LPL mRNA CTD PMID:30556269 cortisol multiple interactions ISO RGD:70836 6480464 Hydrocortisone results in decreased activity of and results in decreased expression of LPL protein CTD PMID:17549480 curcumin affects expression ISO RGD:10876 6480464 Curcumin affects the expression of LPL mRNA CTD PMID:27208389 cytochalasin B decreases activity ISO RGD:10876 6480464 Cytochalasin B results in decreased activity of LPL protein CTD PMID:9414485 D-gluconic acid multiple interactions EXP 6480464 [gluconic acid co-treated with Deoxycholic Acid] results in increased expression of LPL mRNA CTD PMID:16556975 D-glucose multiple interactions ISO RGD:70836 6480464 LPL protein promotes the reaction [Fatty Acids results in increased uptake of Glucose] CTD PMID:20628023 D-glucose decreases activity ISO RGD:10876 6480464 Glucose analog results in decreased activity of LPL protein CTD PMID:9414485 DDT increases expression ISO RGD:70836 6480464 DDT results in increased expression of LPL mRNA CTD PMID:25014179 deoxycholic acid multiple interactions EXP 6480464 [gluconic acid co-treated with Deoxycholic Acid] results in increased expression of LPL mRNA CTD PMID:16556975 Deoxycorticosterone acetate multiple interactions EXP 6480464 [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of LPL mRNA CTD PMID:22228705 dexamethasone multiple interactions ISO RGD:70836 6480464 [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of LPL protein more ... CTD PMID:19186324 more ... dexamethasone increases expression ISO RGD:10876 6480464 Dexamethasone results in increased expression of LPL protein CTD PMID:26018136 dexamethasone increases expression ISO RGD:70836 6480464 Dexamethasone results in increased expression of LPL mRNA, Dexamethasone results in increased expression of LPL protein CTD PMID:25047013 , PMID:27003841 dexamethasone affects expression ISO RGD:10876 6480464 Dexamethasone affects the expression of LPL mRNA CTD PMID:22733784 dexamethasone multiple interactions EXP 6480464 Progesterone inhibits the reaction [Dexamethasone results in increased activity of LPL protein] CTD PMID:12906939 dexamethasone increases activity EXP 6480464 Dexamethasone results in increased activity of LPL protein CTD PMID:12906939 dexamethasone multiple interactions ISO RGD:10876 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of LPL mRNA] more ... CTD PMID:16054899 more ... diarsenic trioxide decreases expression ISO RGD:70836 6480464 Arsenic Trioxide results in decreased expression of LPL mRNA CTD PMID:19128835 , PMID:26705709 dibenz[a,h]anthracene decreases expression ISO RGD:10876 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate multiple interactions ISO RGD:70836 6480464 [Dibutyl Phthalate co-treated with Tetradecanoylphorbol Acetate] results in increased expression of LPL protein CTD PMID:30218697 dibutyl phthalate multiple interactions ISO RGD:10876 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of LPL mRNA CTD PMID:30768133 dibutylstannane increases expression ISO RGD:10876 6480464 di-n-butyltin results in increased expression of LPL mRNA CTD PMID:29787037 dibutylstannane multiple interactions ISO RGD:10876 6480464 T 0070907 inhibits the reaction [di-n-butyltin results in increased expression of LPL mRNA] CTD PMID:29787037 dibutylstannane increases expression ISO RGD:70836 6480464 di-n-butyltin results in increased expression of LPL mRNA CTD PMID:29787037 dibutylstannane multiple interactions ISO RGD:70836 6480464 T 0070907 inhibits the reaction [di-n-butyltin results in increased expression of LPL mRNA] CTD PMID:29787037 dichlorvos decreases activity EXP 6480464 Dichlorvos results in decreased activity of LPL protein CTD PMID:3196159 diclofenac increases expression ISO RGD:10876 6480464 Diclofenac results in increased expression of LPL mRNA CTD PMID:26934552 diethyl phthalate multiple interactions ISO RGD:10876 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of LPL mRNA CTD PMID:30768133 diethylstilbestrol increases expression ISO RGD:10876 6480464 Diethylstilbestrol results in increased expression of LPL mRNA CTD PMID:22710028 diethylstilbestrol multiple interactions ISO RGD:10876 6480464 [troglitazone co-treated with Diethylstilbestrol] results in increased expression of LPL protein CTD PMID:22710028 diisobutyl phthalate multiple interactions ISO RGD:10876 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of LPL mRNA CTD PMID:30768133 diisononyl phthalate multiple interactions ISO RGD:10876 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of LPL mRNA CTD PMID:30768133 dimethylarsinic acid decreases expression ISO RGD:70836 6480464 Cacodylic Acid results in decreased expression of LPL mRNA CTD PMID:23221991 dioxygen increases expression ISO RGD:70836 6480464 Oxygen deficiency results in increased expression of LPL mRNA CTD PMID:24236059 diuron decreases expression EXP 6480464 Diuron results in decreased expression of LPL mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:70836 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPL mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:70836 6480464 Doxorubicin results in decreased expression of LPL mRNA CTD PMID:29803840 duvoglustat multiple interactions ISO RGD:10876 6480464 [1-Deoxynojirimycin co-treated with Polysaccharides] inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of LPL mRNA] CTD PMID:25446853 efavirenz decreases expression ISO RGD:70836 6480464 efavirenz results in decreased expression of LPL mRNA CTD PMID:21619898 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of LPL mRNA CTD PMID:29391264 enilconazole increases expression ISO RGD:70836 6480464 enilconazole results in increased expression of LPL mRNA CTD PMID:32201337 entinostat decreases expression ISO RGD:70836 6480464 entinostat results in decreased expression of LPL mRNA CTD PMID:27188386 erythromycin estolate increases expression EXP 6480464 Erythromycin Estolate results in increased expression of LPL mRNA CTD PMID:17522070 ethanol decreases expression ISO RGD:10876 6480464 Ethanol results in decreased expression of LPL mRNA CTD PMID:22173916 ethanol affects splicing ISO RGD:10876 6480464 Ethanol affects the splicing of LPL mRNA CTD PMID:30319688 ethanol decreases activity EXP 6480464 Ethanol results in decreased activity of LPL protein CTD PMID:28442378 ethanol multiple interactions EXP 6480464 zingerone inhibits the reaction [Ethanol results in decreased activity of LPL protein] CTD PMID:28442378 ethanol increases expression ISO RGD:10876 6480464 Ethanol results in increased expression of LPL mRNA CTD PMID:21955143 ethanol multiple interactions ISO RGD:10876 6480464 rosiglitazone inhibits the reaction [Ethanol results in decreased expression of LPL mRNA] CTD PMID:22173916 etofibrate multiple interactions EXP 6480464 [etofibrate co-treated with Heparin] results in increased secretion of LPL protein CTD PMID:3179329 fenofibrate increases expression ISO RGD:10876 6480464 Fenofibrate results in increased expression of LPL mRNA, Fenofibrate results in increased expression of LPL protein CTD PMID:11798191 , PMID:24752549 fenofibrate increases expression ISO RGD:70836 6480464 Fenofibrate results in increased expression of LPL mRNA, Fenofibrate results in increased expression of LPL protein CTD PMID:24752549 fenofibrate multiple interactions ISO RGD:10876 6480464 PPARA gene mutant form inhibits the reaction [Fenofibrate results in increased expression of LPL mRNA], PPARA gene mutant form inhibits the reaction [Fenofibrate results in increased expression of LPL protein] CTD PMID:24752549 fenofibrate multiple interactions ISO RGD:70836 6480464 PPARA protein promotes the reaction [Fenofibrate results in increased expression of LPL protein] CTD PMID:24752549 fenofibrate multiple interactions EXP 6480464 Fenofibrate inhibits the reaction [Pyrazinamide results in decreased expression of LPL mRNA] CTD PMID:27071702 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of LPL mRNA CTD PMID:16595124 , PMID:27071702 fenofibrate increases activity ISO RGD:70836 6480464 Fenofibrate results in increased activity of LPL protein CTD PMID:8593127 fluvastatin multiple interactions ISO RGD:70836 6480464 [ABCA1 gene SNP co-treated with CETP gene SNP co-treated with LIPC gene SNP co-treated with LPL gene SNP] affects the susceptibility to fluvastatin, [APOB gene SNP co-treated with APOE gene SNP co-treated with HMGCR gene SNP co-treated with LDLR gene SNP co-treated with PCSK9 gene SNP co-treated with ABCA1 gene SNP co-treated with CETP gene SNP co-treated with LIPC gene SNP co-treated with LPL gene SNP] affects the susceptibility to fluvastatin CTD PMID:19773416 folic acid multiple interactions ISO RGD:10876 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of LPL mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LPL mRNA CTD PMID:20938992 , PMID:29127188 fulvestrant multiple interactions ISO RGD:10876 6480464 Fulvestrant inhibits the reaction [bisphenol A glucuronide results in increased expression of LPL protein] more ... CTD PMID:17974624 , PMID:26018136 fulvestrant decreases expression ISO RGD:10876 6480464 fulvestrant results in decreased expression of LPL mRNA CTD PMID:17974624 fumonisin B1 increases expression ISO RGD:10876 6480464 fumonisin B1 results in increased expression of LPL mRNA CTD PMID:16221962 furan decreases methylation EXP 6480464 furan results in decreased methylation of LPL gene CTD PMID:27387713 furan increases expression EXP 6480464 furan results in increased expression of LPL mRNA CTD PMID:27387713 gemfibrozil increases activity ISO RGD:70836 6480464 Gemfibrozil results in increased activity of LPL protein CTD PMID:8593127 gemfibrozil increases activity EXP 6480464 Gemfibrozil results in increased activity of LPL protein CTD PMID:9006809 gemfibrozil multiple interactions EXP 6480464 [Gemfibrozil results in increased activity of LPL protein] which results in decreased abundance of Triglycerides CTD PMID:9006809 genistein decreases activity ISO RGD:10876 6480464 Genistein results in decreased activity of LPL protein CTD PMID:9414485 genistein increases expression EXP 6480464 Genistein results in increased expression of LPL mRNA CTD PMID:21782745 ginsenoside Rb2 increases secretion ISO RGD:10876 6480464 ginsenoside Rb2 results in increased secretion of LPL protein CTD PMID:8988629 ginsenoside Rb2 decreases secretion ISO RGD:10876 6480464 ginsenoside Rb2 results in decreased secretion of LPL protein CTD PMID:8988629 ginsenoside Rd decreases secretion ISO RGD:10876 6480464 ginsenoside Rd results in decreased secretion of LPL protein CTD PMID:8988629 ginsenoside Re increases secretion ISO RGD:10876 6480464 ginsenoside Re results in increased secretion of LPL protein CTD PMID:8988629 ginsenoside Rg1 increases secretion ISO RGD:10876 6480464 ginsenoside Rg1 results in increased secretion of LPL protein CTD PMID:8988629 glucose multiple interactions ISO RGD:70836 6480464 LPL protein promotes the reaction [Fatty Acids results in increased uptake of Glucose] CTD PMID:20628023 glucose decreases activity ISO RGD:10876 6480464 Glucose analog results in decreased activity of LPL protein CTD PMID:9414485 griseofulvin affects expression ISO RGD:10876 6480464 Griseofulvin affects the expression of LPL mRNA CTD PMID:12735108 guggulsterone multiple interactions ISO RGD:10876 6480464 pregna-4 more ... CTD PMID:27773935 heparin multiple interactions EXP 6480464 [etofibrate co-treated with Heparin] results in increased secretion of LPL protein CTD PMID:3179329 Heptachlor epoxide decreases expression ISO RGD:10876 6480464 Heptachlor Epoxide results in decreased expression of LPL mRNA CTD PMID:25270620 hesperetin decreases expression ISO RGD:70836 6480464 hesperetin results in decreased expression of LPL mRNA CTD PMID:25345581 high-density lipoprotein cholesterol affects abundance ISO RGD:70836 6480464 LPL gene polymorphism affects the abundance of Cholesterol, HDL CTD PMID:16030523 hydrogen peroxide decreases expression ISO RGD:70836 6480464 Hydrogen Peroxide results in decreased expression of LPL mRNA CTD PMID:26339600 indinavir decreases activity ISO RGD:10876 6480464 Indinavir results in decreased activity of LPL protein CTD PMID:11786383 indinavir multiple interactions ISO RGD:10876 6480464 [Stavudine co-treated with Lamivudine co-treated with Indinavir] affects the expression of LPL mRNA, [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of LPL mRNA CTD PMID:11741158 indinavir increases expression ISO RGD:10876 6480464 Indinavir results in increased expression of LPL mRNA CTD PMID:11741158 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of LPL mRNA CTD PMID:21396975 indometacin multiple interactions ISO RGD:10876 6480464 Indomethacin inhibits the reaction [APC gene mutant form results in decreased expression of LPL mRNA] CTD PMID:17546600 indometacin multiple interactions ISO RGD:70836 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of LPL mRNA more ... CTD PMID:23086663 , PMID:28628672 isoprenaline multiple interactions EXP 6480464 cirazoline promotes the reaction [Isoproterenol results in increased expression of LPL mRNA], naringin inhibits the reaction [Isoproterenol results in decreased activity of LPL protein] CTD PMID:16906524 , PMID:9032464 isoprenaline decreases expression ISO RGD:10876 6480464 Isoproterenol results in decreased expression of LPL mRNA CTD PMID:21335049 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of LPL mRNA CTD PMID:9032464 isoprenaline decreases activity EXP 6480464 Isoproterenol results in decreased activity of LPL protein CTD PMID:16906524 L-methionine multiple interactions ISO RGD:10876 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of LPL mRNA more ... CTD PMID:20938992 more ... lamivudine decreases expression ISO RGD:10876 6480464 Lamivudine results in decreased expression of LPL mRNA CTD PMID:11741158 lamivudine multiple interactions ISO RGD:10876 6480464 [Stavudine co-treated with Lamivudine co-treated with Indinavir] affects the expression of LPL mRNA more ... CTD PMID:11741158 lead diacetate increases expression ISO RGD:10876 6480464 lead acetate results in increased expression of LPL mRNA CTD PMID:21829687 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of LPL mRNA CTD PMID:24136188 linalool increases expression ISO RGD:70836 6480464 linalool results in increased expression of LPL mRNA, linalool results in increased expression of LPL protein CTD PMID:24752549 linalool multiple interactions ISO RGD:10876 6480464 PPARA gene mutant form inhibits the reaction [linalool results in increased expression of LPL mRNA], PPARA gene mutant form inhibits the reaction [linalool results in increased expression of LPL protein] CTD PMID:24752549 linalool increases expression ISO RGD:10876 6480464 linalool results in increased expression of LPL mRNA, linalool results in increased expression of LPL protein CTD PMID:24752549 linalool multiple interactions ISO RGD:70836 6480464 PPARA protein promotes the reaction [linalool results in increased expression of LPL protein] CTD PMID:24752549 lipopolysaccharide multiple interactions ISO RGD:10876 6480464 pyrazolanthrone inhibits the reaction [Lipopolysaccharides results in decreased expression of LPL mRNA] CTD PMID:21873422 lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of LPL mRNA CTD PMID:17379010 lipopolysaccharide multiple interactions EXP 6480464 Bezafibrate inhibits the reaction [Lipopolysaccharides results in decreased expression of LPL mRNA] CTD PMID:17379010 lipopolysaccharide decreases expression ISO RGD:10876 6480464 Lipopolysaccharides results in decreased expression of LPL mRNA CTD PMID:21873422 lithocholic acid increases expression ISO RGD:10876 6480464 Lithocholic Acid results in increased expression of LPL mRNA CTD PMID:20359477 lovastatin affects expression ISO RGD:10876 6480464 Lovastatin affects the expression of LPL mRNA CTD PMID:27208389 lovastatin multiple interactions ISO RGD:10876 6480464 [Dietary Fats co-treated with Lovastatin] affects the expression of LPL mRNA CTD PMID:29852127 LY294002 multiple interactions ISO RGD:70836 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [LPL protein promotes the reaction [IFNG protein results in increased expression of GBP1 mRNA]], 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [LPL protein promotes the reaction [IFNG protein results in increased expression of ICAM1 mRNA]] CTD PMID:15994321 LY294002 multiple interactions ISO RGD:10876 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of LPL mRNA] CTD PMID:15659569 mangiferin multiple interactions ISO RGD:70836 6480464 MK-886 inhibits the reaction [mangiferin results in increased activity of LPL protein], MK-886 inhibits the reaction [mangiferin results in increased expression of LPL mRNA] CTD PMID:15975614 mangiferin increases activity ISO RGD:70836 6480464 mangiferin results in increased activity of LPL protein CTD PMID:15975614 mangiferin increases expression ISO RGD:70836 6480464 mangiferin results in increased expression of LPL mRNA CTD PMID:15975614 melatonin decreases expression ISO RGD:70836 6480464 Melatonin results in decreased expression of LPL mRNA CTD PMID:20738756 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of LPL mRNA CTD PMID:28935588 methylmercury chloride decreases expression ISO RGD:70836 6480464 methylmercuric chloride results in decreased expression of LPL mRNA CTD PMID:28001369 mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of LPL mRNA CTD PMID:25972201 mifepristone increases expression ISO RGD:10876 6480464 Mifepristone results in increased expression of LPL protein CTD PMID:26018136 monocrotophos increases expression EXP 6480464 Monocrotophos results in increased expression of LPL mRNA CTD PMID:32267039 morphine increases expression ISO RGD:10876 6480464 Morphine results in increased expression of LPL mRNA CTD PMID:21955143 myricetin multiple interactions EXP 6480464 myricetin inhibits the reaction [[Streptozocin co-treated with Cadmium] results in decreased activity of LPL protein] CTD PMID:25240712 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO RGD:10876 6480464 [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of LPL mRNA more ... CTD PMID:19840844 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LPL mRNA CTD PMID:18164116 N-nitrosodiethylamine increases expression ISO RGD:10876 6480464 Diethylnitrosamine results in increased expression of LPL mRNA CTD PMID:12771043 , PMID:24535843 N-nitrosodiethylamine multiple interactions ISO RGD:10876 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LPL mRNA CTD PMID:24535843 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of LPL mRNA CTD PMID:25380136 naringin multiple interactions EXP 6480464 naringin inhibits the reaction [Isoproterenol results in decreased activity of LPL protein] CTD PMID:16906524 nelfinavir multiple interactions ISO RGD:10876 6480464 [Stavudine co-treated with Lamivudine co-treated with Nelfinavir] results in decreased expression of LPL mRNA CTD PMID:11741158 nelfinavir decreases expression ISO RGD:10876 6480464 Nelfinavir results in decreased expression of LPL mRNA CTD PMID:11741158 nevirapine increases expression ISO RGD:70836 6480464 Nevirapine results in increased expression of LPL mRNA CTD PMID:21619898 nickel atom decreases expression ISO RGD:70836 6480464 Nickel results in decreased expression of LPL mRNA CTD PMID:24768652 , PMID:25583101 nicotinamide multiple interactions EXP 6480464 [Streptozocin co-treated with Niacinamide] results in decreased activity of LPL protein more ... CTD PMID:20696151 nicotine increases expression ISO RGD:10876 6480464 Nicotine results in increased expression of LPL mRNA CTD PMID:21955143 ochratoxin A decreases expression ISO RGD:70836 6480464 ochratoxin A results in decreased expression of LPL CTD PMID:20590410 okadaic acid multiple interactions ISO RGD:10876 6480464 [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of LPL mRNA CTD PMID:19840844 orlistat decreases activity ISO RGD:10876 6480464 orlistat results in decreased activity of LPL protein CTD PMID:12388125 orlistat multiple interactions ISO RGD:10876 6480464 [orlistat results in decreased activity of LPL protein] which affects the uptake of Triglycerides CTD PMID:12388125 orlistat decreases activity ISO RGD:70836 6480464 orlistat results in decreased activity of LPL protein CTD PMID:15994321 , PMID:18698144 orlistat multiple interactions ISO RGD:70836 6480464 orlistat inhibits the reaction [[LPL protein results in increased hydrolysis of Triglycerides] which results in increased uptake of Triglycerides] more ... CTD PMID:12573449 more ... orlistat multiple interactions EXP 6480464 orlistat inhibits the reaction [Dietary Fats results in decreased expression of LPL protein] CTD PMID:25087745 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of LPL mRNA CTD PMID:23665939 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of LPL mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of LPL mRNA CTD PMID:25729387 paracetamol multiple interactions ISO RGD:10876 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of LPL mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of LPL mRNA] CTD PMID:17585979 paracetamol affects response to substance ISO RGD:10876 6480464 LPL mRNA affects the susceptibility to Acetaminophen CTD PMID:27530116 paracetamol decreases expression ISO RGD:10876 6480464 Acetaminophen results in decreased expression of LPL mRNA CTD PMID:15030884 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of LPL mRNA CTD PMID:17077588 PD 0325901 multiple interactions ISO RGD:70836 6480464 [PD 0325901 co-treated with (+)-JQ1 compound] results in decreased expression of LPL mRNA CTD PMID:25119042 perfluorohexanesulfonic acid increases expression ISO RGD:10876 6480464 perfluorohexanesulfonic acid results in increased expression of LPL mRNA CTD PMID:21705711 , PMID:28049043 perfluorohexanesulfonic acid multiple interactions ISO RGD:10876 6480464 PPARA gene mutant form inhibits the reaction [perfluorohexanesulfonic acid results in increased expression of LPL mRNA] CTD PMID:28049043 perfluorononanoic acid multiple interactions ISO RGD:10876 6480464 PPARA gene mutant form inhibits the reaction [perfluorononanoic acid results in increased expression of LPL mRNA] CTD PMID:28049043 perfluorononanoic acid increases expression ISO RGD:10876 6480464 perfluorononanoic acid results in increased expression of LPL mRNA CTD PMID:28049043 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of LPL mRNA CTD PMID:18692542 perfluorooctane-1-sulfonic acid affects expression ISO RGD:70836 6480464 perfluorooctane sulfonic acid affects the expression of LPL mRNA CTD PMID:30738844 perfluorooctane-1-sulfonic acid increases expression ISO RGD:70836 6480464 perfluorooctane sulfonic acid results in increased expression of LPL mRNA CTD PMID:28011154 perfluorooctane-1-sulfonic acid increases expression ISO RGD:10876 6480464 perfluorooctane sulfonic acid results in increased expression of LPL mRNA CTD PMID:21705711 , PMID:26548598 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of LPL mRNA CTD PMID:16221955 , PMID:19162173 perfluorooctanoic acid multiple interactions ISO RGD:10876 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of LPL mRNA] more ... CTD PMID:23626681 more ... perfluorooctanoic acid increases expression ISO RGD:10876 6480464 perfluorooctanoic acid results in increased expression of LPL mRNA CTD PMID:23626681 more ... permethrin increases expression ISO RGD:10876 6480464 Permethrin results in increased expression of LPL mRNA CTD PMID:24911977 , PMID:30629241 phencyclidine increases expression ISO RGD:10876 6480464 Phencyclidine results in increased expression of LPL mRNA CTD PMID:17266109 phenobarbital multiple interactions ISO RGD:10876 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LPL mRNA, NR1I3 protein affects the reaction [Phenobarbital results in increased expression of LPL mRNA] CTD PMID:19482888 , PMID:24535843 phenobarbital affects expression ISO RGD:10876 6480464 Phenobarbital affects the expression of LPL mRNA CTD PMID:19136022 , PMID:23091169 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of LPL mRNA CTD PMID:22008526 , PMID:22008536 phenobarbital increases expression ISO RGD:10876 6480464 Phenobarbital results in increased expression of LPL mRNA CTD PMID:19482888 , PMID:31836555 Phenylamil increases expression ISO RGD:10876 6480464 phenylamil results in increased expression of LPL mRNA CTD PMID:20519739 phenylephrine affects response to substance ISO RGD:70836 6480464 LPL protein affects the susceptibility to Phenylephrine CTD PMID:11786490 PhIP decreases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in decreased expression of LPL mRNA CTD PMID:12376462 , PMID:15059925 phorbol 13-acetate 12-myristate increases expression ISO RGD:70836 6480464 Tetradecanoylphorbol Acetate results in increased expression of LPL protein CTD PMID:18435438 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:70836 6480464 [Dibutyl Phthalate co-treated with Tetradecanoylphorbol Acetate] results in increased expression of LPL protein CTD PMID:30218697 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:10876 6480464 [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of LPL mRNA CTD PMID:19840844 picrotoxin decreases expression EXP 6480464 Picrotoxin results in decreased expression of LPL mRNA CTD PMID:15170462 piperine multiple interactions EXP 6480464 piperine inhibits the reaction [Dietary Fats results in decreased expression of LPL protein] CTD PMID:25087745 pirinixic acid affects expression ISO RGD:10876 6480464 pirinixic acid affects the expression of LPL mRNA CTD PMID:19136022 pirinixic acid increases expression ISO RGD:10876 6480464 pirinixic acid results in increased expression of LPL mRNA CTD PMID:11798191 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of LPL mRNA CTD PMID:19162173 pirinixic acid multiple interactions ISO RGD:10876 6480464 PPARA gene mutant form inhibits the reaction [pirinixic acid results in increased expression of LPL mRNA] more ... CTD PMID:16221962 more ... pirinixic acid decreases expression ISO RGD:10876 6480464 pirinixic acid results in decreased expression of LPL mRNA CTD PMID:18445702 platycodin D decreases expression ISO RGD:10876 6480464 platycodin D results in decreased expression of LPL mRNA CTD PMID:20024897 potassium chloride increases response to substance ISO RGD:70836 6480464 LPL protein results in increased susceptibility to Potassium Chloride CTD PMID:11786490 potassium chloride multiple interactions EXP 6480464 [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of LPL mRNA CTD PMID:22228705 pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of LPL mRNA CTD PMID:27225895 pravastatin decreases expression ISO RGD:10876 6480464 Pravastatin results in decreased expression of LPL mRNA CTD PMID:27225895 prazosin multiple interactions EXP 6480464 Prazosin inhibits the reaction [Norepinephrine results in increased expression of LPL mRNA] CTD PMID:9032464 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of LPL mRNA CTD PMID:19162173 proanthocyanidin multiple interactions EXP 6480464 Proanthocyanidins inhibits the reaction [[Cholesterol co-treated with Cholic Acid] results in increased activity of LPL protein] CTD PMID:30273964 progesterone affects expression ISO RGD:10876 6480464 Progesterone affects the expression of LPL mRNA CTD PMID:17251523 progesterone increases expression EXP 6480464 Progesterone results in increased expression of LPL mRNA CTD PMID:20726854 progesterone multiple interactions EXP 6480464 Progesterone inhibits the reaction [Dexamethasone results in increased activity of LPL protein] CTD PMID:12906939 progesterone decreases expression ISO RGD:10876 6480464 Progesterone results in decreased expression of LPL mRNA CTD PMID:17974624 progesterone multiple interactions ISO RGD:10876 6480464 Progesterone inhibits the reaction [ESR1 protein promotes the reaction [Estradiol results in increased expression of LPL mRNA]] more ... CTD PMID:17974624 propamocarb increases expression ISO RGD:10876 6480464 propamocarb results in increased expression of LPL mRNA CTD PMID:29137890 propranolol multiple interactions EXP 6480464 Propranolol inhibits the reaction [Norepinephrine results in increased expression of LPL mRNA] CTD PMID:9032464 pyrazinecarboxamide multiple interactions EXP 6480464 Fenofibrate inhibits the reaction [Pyrazinamide results in decreased expression of LPL mRNA] CTD PMID:27071702 pyrazinecarboxamide decreases expression EXP 6480464 Pyrazinamide results in decreased expression of LPL mRNA CTD PMID:27071702 raloxifene multiple interactions ISO RGD:70836 6480464 [Raloxifene Hydrochloride co-treated with ESR1 protein] results in increased expression of LPL mRNA CTD PMID:19059307 raloxifene increases expression ISO RGD:10876 6480464 Raloxifene Hydrochloride results in increased expression of LPL mRNA CTD PMID:16643890 resveratrol decreases expression ISO RGD:10876 6480464 resveratrol metabolite results in decreased expression of LPL mRNA, resveratrol results in decreased expression of LPL mRNA CTD PMID:18555852 more ... resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of LPL mRNA CTD PMID:23848300 , PMID:24012391 resveratrol decreases activity EXP 6480464 resveratrol results in decreased activity of LPL protein CTD PMID:21569266 , PMID:24012391 resveratrol decreases expression ISO RGD:70836 6480464 resveratrol results in decreased expression of LPL mRNA CTD PMID:16901463 ritonavir affects expression ISO RGD:10876 6480464 Ritonavir affects the expression of LPL mRNA CTD PMID:11741158 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of LPL mRNA CTD PMID:19693701 rotenone increases expression EXP 6480464 Rotenone results in increased expression of LPL mRNA CTD PMID:28374803 saquinavir decreases activity ISO RGD:10876 6480464 Saquinavir results in decreased activity of LPL protein CTD PMID:11786383 saquinavir decreases expression ISO RGD:10876 6480464 Saquinavir results in decreased expression of LPL mRNA CTD PMID:11741158 SB 431542 multiple interactions ISO RGD:70836 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPL mRNA CTD PMID:27188386 simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of LPL CTD PMID:19216230 simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of LPL protein CTD PMID:2009092 sodium arsenate decreases expression ISO RGD:70836 6480464 sodium arsenate analog results in decreased expression of LPL mRNA CTD PMID:23221991 sodium arsenite multiple interactions ISO RGD:70836 6480464 sodium arsenite results in decreased expression of and affects the splicing of LPL mRNA CTD PMID:25879800 sodium arsenite decreases expression ISO RGD:10876 6480464 sodium arsenite results in decreased expression of LPL mRNA CTD PMID:23221991 sodium arsenite affects expression ISO RGD:10876 6480464 sodium arsenite affects the expression of LPL mRNA CTD PMID:16507464 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of LPL mRNA CTD PMID:25993096 stavudine multiple interactions ISO RGD:10876 6480464 [Stavudine co-treated with Lamivudine co-treated with Indinavir] affects the expression of LPL mRNA more ... CTD PMID:11741158 streptozocin multiple interactions EXP 6480464 [Streptozocin co-treated with Cadmium] results in decreased activity of LPL protein more ... CTD PMID:20696151 , PMID:25240712 streptozocin multiple interactions ISO RGD:10876 6480464 [1-Deoxynojirimycin co-treated with Polysaccharides] inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of LPL mRNA] more ... CTD PMID:25446853 , PMID:29127188 sulforaphane increases expression ISO RGD:10876 6480464 sulforafan results in increased expression of LPL mRNA CTD PMID:30529165 sunitinib increases expression ISO RGD:70836 6480464 Sunitinib results in increased expression of LPL mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:70836 6480464 Tamoxifen affects the expression of LPL mRNA CTD PMID:14699072 tamoxifen decreases expression ISO RGD:70836 6480464 Tamoxifen results in decreased expression of LPL protein CTD PMID:3108557 tamoxifen affects expression ISO RGD:10876 6480464 Tamoxifen affects the expression of LPL mRNA CTD PMID:17555576 , PMID:20937368 tamoxifen multiple interactions ISO RGD:70836 6480464 [Tamoxifen co-treated with ESR1 protein] results in increased expression of LPL mRNA CTD PMID:19059307 tert-butyl hydroperoxide decreases expression ISO RGD:70836 6480464 tert-Butylhydroperoxide results in decreased expression of LPL mRNA CTD PMID:15336504 tetrachloromethane affects expression ISO RGD:10876 6480464 Carbon Tetrachloride affects the expression of LPL mRNA CTD PMID:17484886 , PMID:31919559 tetrachloromethane increases expression ISO RGD:10876 6480464 Carbon Tetrachloride results in increased expression of LPL mRNA CTD PMID:27339419 , PMID:29987408 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of LPL mRNA CTD PMID:17522070 tetrachloromethane multiple interactions ISO RGD:10876 6480464 PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of LPL mRNA] CTD PMID:16006527 tetracycline increases expression EXP 6480464 Tetracycline results in increased expression of LPL mRNA CTD PMID:17522070 tetrahydrocurcumin multiple interactions EXP 6480464 [tetrahydrocurcumin co-treated with Chlorogenic Acid] results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LPL protein], tetrahydrocurcumin results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LPL protein] CTD PMID:20696151 thapsigargin increases expression ISO RGD:70836 6480464 Thapsigargin results in increased expression of LPL mRNA CTD PMID:29453283 theophylline increases expression ISO RGD:70836 6480464 Theophylline results in increased expression of LPL mRNA CTD PMID:16083514 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of LPL mRNA CTD PMID:23411599 topotecan increases expression EXP 6480464 Topotecan results in increased expression of LPL mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of LPL mRNA CTD PMID:25729387 triadimefon increases expression ISO RGD:70836 6480464 triadimefon results in increased expression of LPL mRNA CTD PMID:26705709 tributylstannane multiple interactions ISO RGD:10876 6480464 T 0070907 inhibits the reaction [tributyltin results in increased expression of LPL mRNA], tributyltin promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LPL mRNA] CTD PMID:22197818 , PMID:29787037 tributylstannane multiple interactions ISO RGD:70836 6480464 T 0070907 inhibits the reaction [tributyltin results in increased expression of LPL mRNA] CTD PMID:29787037 tributylstannane increases expression ISO RGD:70836 6480464 tributyltin results in increased expression of LPL mRNA CTD PMID:28011154 , PMID:29787037 tributylstannane increases expression ISO RGD:10876 6480464 tributyltin results in increased expression of LPL mRNA CTD PMID:23322813 more ... trichostatin A decreases expression ISO RGD:70836 6480464 trichostatin A results in decreased expression of LPL mRNA CTD PMID:24935251 triclosan decreases expression ISO RGD:70836 6480464 Triclosan results in decreased expression of LPL mRNA CTD PMID:22726953 triflumizole multiple interactions ISO RGD:70836 6480464 [triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of LPL mRNA, T 0070907 inhibits the reaction [[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of LPL mRNA] CTD PMID:23086663 triflumizole multiple interactions ISO RGD:10876 6480464 [triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of LPL mRNA, T 0070907 inhibits the reaction [[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of LPL mRNA] CTD PMID:23086663 triphenyl phosphate increases expression ISO RGD:70836 6480464 triphenyl phosphate results in increased expression of LPL mRNA CTD PMID:28934090 triphenyl phosphate multiple interactions ISO RGD:70836 6480464 [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of LPL mRNA more ... CTD PMID:28437481 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of LPL mRNA CTD PMID:30589522 triphenyl phosphate increases expression ISO RGD:10876 6480464 triphenyl phosphate results in increased expression of LPL mRNA CTD PMID:28163246 troglitazone multiple interactions ISO RGD:10876 6480464 [troglitazone co-treated with Diethylstilbestrol] results in increased expression of LPL protein more ... CTD PMID:16368784 , PMID:22710028 troglitazone increases expression ISO RGD:10876 6480464 troglitazone results in increased expression of LPL mRNA, troglitazone results in increased expression of LPL protein CTD PMID:10233209 more ... troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of LPL mRNA CTD PMID:21515302 troglitazone multiple interactions ISO RGD:70836 6480464 [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Troglitazone] results in increased expression of LPL protein more ... CTD PMID:10233209 more ... troglitazone increases expression ISO RGD:70836 6480464 troglitazone results in increased expression of LPL protein CTD PMID:10233209 undecane increases expression EXP 6480464 undecane results in increased expression of LPL protein CTD PMID:17337753 valproic acid affects expression ISO RGD:70836 6480464 Valproic Acid affects the expression of LPL mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:70836 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPL mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:70836 6480464 Valproic Acid results in decreased expression of LPL mRNA CTD PMID:23179753 more ... valsartan multiple interactions ISO RGD:10876 6480464 [Valsartan co-treated with AGT protein] results in increased activity of LPL protein CTD PMID:18640387 valsartan increases activity ISO RGD:10876 6480464 Valsartan results in increased activity of LPL protein CTD PMID:18640387 vancomycin increases expression ISO RGD:10876 6480464 Vancomycin results in increased expression of LPL mRNA CTD PMID:18930951 venlafaxine hydrochloride increases expression EXP 6480464 Venlafaxine Hydrochloride results in increased expression of LPL mRNA CTD PMID:25423262 very-low-density lipoprotein triglyceride multiple interactions ISO RGD:70836 6480464 [LPL protein results in increased hydrolysis of very low density lipoprotein triglyceride] which results in increased abundance of Fatty Acids, Unsaturated more ... CTD PMID:12573449 more ... very-low-density lipoprotein triglyceride increases hydrolysis ISO RGD:70836 6480464 LPL protein results in increased hydrolysis of very low density lipoprotein triglyceride CTD PMID:18435438 very-low-density lipoprotein triglyceride increases activity ISO RGD:70836 6480464 very low density lipoprotein triglyceride results in increased activity of LPL protein CTD PMID:12573449 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of LPL mRNA CTD PMID:22570695 , PMID:23869203 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of LPL mRNA CTD PMID:19015723 vorinostat decreases expression ISO RGD:70836 6480464 vorinostat results in decreased expression of LPL mRNA CTD PMID:27188386 yohimbine multiple interactions ISO RGD:10876 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of LPL mRNA CTD PMID:28843594 zaragozic acid A decreases expression EXP 6480464 squalestatin 1 results in decreased expression of LPL mRNA CTD PMID:27225895 zaragozic acid A decreases expression ISO RGD:10876 6480464 squalestatin 1 results in decreased expression of LPL mRNA CTD PMID:27225895 zidovudine decreases expression ISO RGD:70836 6480464 Zidovudine results in decreased expression of LPL mRNA CTD PMID:16894629 zidovudine affects expression ISO RGD:70836 6480464 Zidovudine affects the expression of LPL mRNA CTD PMID:20032539 zidovudine multiple interactions ISO RGD:10876 6480464 [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of LPL mRNA, [Zidovudine co-treated with Lamivudine] results in decreased expression of LPL mRNA CTD PMID:11741158 zidovudine decreases expression ISO RGD:10876 6480464 Zidovudine results in decreased expression of LPL mRNA CTD PMID:11741158 zinc atom affects expression EXP 6480464 Zinc affects the expression of LPL mRNA CTD PMID:17181878 zinc atom decreases expression ISO RGD:10876 6480464 Zinc deficiency results in decreased expression of LPL mRNA CTD PMID:20857495 zinc(0) affects expression EXP 6480464 Zinc affects the expression of LPL mRNA CTD PMID:17181878 zinc(0) decreases expression ISO RGD:10876 6480464 Zinc deficiency results in decreased expression of LPL mRNA CTD PMID:20857495 zingerone multiple interactions EXP 6480464 zingerone inhibits the reaction [Ethanol results in decreased activity of LPL protein] CTD PMID:28442378
Gene-Chemical Interaction Annotations
